As per the research report, the size of the Europe Gamma Knife Market is valued at USD 52.22 million in 2019 and estimated to be growing at a CAGR of 8.46%, to reach USD 78.33 million by 2024. Gamma knife is a radiation therapy which is highly focused for spinal or brain cancer which involves a high-dose radiation therapy in a single treatment.
Radiation therapy is a procedure which entails accurate delivery of radiation of high doses to tumors and other appropriate anatomical targets. Gamma Knife is an important form of radiation therapy. It is chiefly used to treat arteriovenous malformations, brain tumors, acoustic neuroma, trigeminal neuralgia and pituitary tumors. In Gamma Knife beam procedure, specialized equipment focuses close to a couple of hundred tiny beams of radiation on a tumor or other targeted cells. These beams deliver powerful doses of radiation to specific tumor cells with refined accuracy. This effectively implies that surrounding healthy tissues are exposed to minimum or no radiation whatsoever.
The driving factors of Europe Gamma Knife market are growing prevalence of cancer, obesity and rising aging population. Also, growing number of initiatives which are undertaken by several government associations and the state-of-the-art features of Gamma Knife systems are also propelling the growth of the market. However, the market is constrained by factors such as prolonged approval time for Gamma Knife systems and stringent regulatory framework, high price of implementation and shortage of skilled manpower among others.
This research report segmented and sub-segmented into the following categories:
Brain metastasis holds the largest market share for gamma knife, accounting to more than sixty percent of share. The others segment is expected to grow at the fastest rate during the forecast period.
The Europe Gamma Knife market is divided based on geography into United Kingdom, France, Germany, Italy and Spain. Europe region has the third largest market for gamma knife in the world by share. Factors such as growing prevalence of cancer and rising aging population are expected to drive the market growth in the forecast period.
Key players operating in the Europe Gamma Knife Market profiled in this report are
Varian Medical Systems, Elekta AB, Cyber Medical Corporation Ltd., Huiheng Medical Inc., Masep Infini Europe, Inc., Hokai, Nordion Inc., ET Medical group and American Shared Hospital Services among others.
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3.1 Executive Summary
3.2 Key Inferences
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1 Disease Indication
5.1.1 Brain Metastasis
5.1.3 Trigeminal Neuralgia
5.1.4 AVM (Arteriovenous Malformation)
5.1.6 Y-o-Y Growth Analysis, By Disease Indication
5.1.7 Market Attractiveness Analysis, By Disease Indication
5.1.8 Market Share Analysis, By Disease Indication
6. Geographical Analysis
6.1.1 Regional Trends
6.1.2 Impact Analysis
6.1.3 Y-o-Y Growth Analysis
220.127.116.11 By Disease Indication
6.1.4 Market Attractiveness Analysis
18.104.22.168 By Disease Indication
6.1.5 Market Share Analysis
22.214.171.124 By Disease Indication
7. Strategic Analysis
7.1 PESTLE analysis
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8. Market Leaders' Analysis
8.1 Varian Medical Systems
8.1.2 Product Analysis
8.1.3 Financial analysis
8.1.4 Recent Developments
8.1.5 SWOT analysis
8.1.6 Analyst View
8.2 Elekta AB
8.3 Cyber Medical Corporation Ltd.
8.4 Huiheng Medical Inc.
8.5 Masep Infini Global, Inc.
8.7 Nordion Inc.
8.8 ET Medical group
8.9 American Shared Hospital Services
9. Competitive Landscape
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
10. Market Outlook and Investment Opportunities
a) List of Tables
b) List of Figures